Huntington National Bank Abb Vie Inc. Transaction History

Huntington National Bank

$12.3 Billion
Q1 2024

A detailed history of Huntington National Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Huntington National Bank holds 516,363 shares of ABBV stock, worth $88.6 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

516,363

Previous 527,707 2.15%

Holding current value

$88.6 Million

Previous $81.8 Million 14.98%

% of portfolio

0.77%

Previous 0.75%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $1.81 Million - $2.07 Million	-11,344 Reduced 2.15%	516,363 $94 Million
Q4 2023 Feb 07, 2024	SELL	$137.6 - $154.97 $3.2 Million - $3.6 Million	-23,233 Reduced 4.22%	527,707 $81.8 Million
Q3 2023 Nov 08, 2023	SELL	$133.59 - $154.65 $4.07 Million - $4.71 Million	-30,478 Reduced 5.24%	550,940 $82.1 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $5.57 Million - $6.93 Million	-42,001 Reduced 6.74%	581,418 $78.3 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $22 Million - $25.3 Million	-152,011 Reduced 19.6%	623,419 $99.4 Million

Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $4.42 Million - $5.3 Million	31,974 Added 4.3%	775,430 $125 Million
Q3 2022 Nov 07, 2022	BUY	$134.21 - $153.93 $8.06 Million - $9.25 Million	60,065 Added 8.79%	743,456 $99.8 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $23.7 Million - $30.1 Million	172,196 Added 33.68%	683,391 $105 Million
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $1.29 Million - $1.6 Million	9,795 Added 1.95%	511,195 $82.9 Million
Q4 2021 Jan 21, 2022	SELL	$107.43 - $135.93 $412,423 - $521,835	-3,839 Reduced 0.76%	501,400 $67.9 Million
Q3 2021 Oct 28, 2021	SELL	$106.4 - $120.78 $377,188 - $428,165	-3,545 Reduced 0.7%	505,239 $54.5 Million
Q2 2021 Jul 30, 2021	BUY	$105.21 - $117.21 $9 Million - $10 Million	85,537 Added 20.21%	508,784 $57.3 Million
Q1 2021 Apr 12, 2021	SELL	$102.3 - $112.62 $1.06 Million - $1.16 Million	-10,328 Reduced 2.38%	423,247 $45.8 Million
Q4 2020 Jan 11, 2021	SELL	$80.49 - $108.67 $198,166 - $267,545	-2,462 Reduced 0.56%	433,575 $46.5 Million
Q3 2020 Oct 30, 2020	SELL	$85.91 - $100.83 $213,744 - $250,865	-2,488 Reduced 0.57%	436,037 $38.2 Million
Q2 2020 Jul 30, 2020	SELL	$73.37 - $98.18 $20,323 - $27,195	-277 Reduced 0.06%	438,525 $43.1 Million
Q1 2020 Apr 27, 2020	SELL	$64.5 - $97.79 $2.01 Million - $3.05 Million	-31,197 Reduced 6.64%	438,802 $33.4 Million
Q4 2019 Jan 17, 2020	SELL	$72.13 - $90.25 $1.22 Million - $1.52 Million	-16,863 Reduced 3.46%	469,999 $41.6 Million
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $4.69 Million - $5.64 Million	74,528 Added 18.07%	486,862 $36.9 Million
Q2 2019 Jul 23, 2019	SELL	$65.7 - $83.98 $1.71 Million - $2.18 Million	-25,973 Reduced 5.93%	412,334 $30 Million
Q1 2019 Apr 09, 2019	SELL	$77.14 - $90.79 $5.29 Million - $6.22 Million	-68,526 Reduced 13.52%	438,307 $35.3 Million
Q4 2018 Jan 28, 2019	SELL	$77.85 - $96.01 $1.36 Million - $1.68 Million	-17,474 Reduced 3.33%	506,833 $46.7 Million
Q3 2018 Oct 18, 2018	BUY	$88.91 - $98.84 $438,770 - $487,775	4,935 Added 0.95%	524,307 $49.6 Million
Q2 2018 Jul 19, 2018	BUY	$89.78 - $106.23 $718,778 - $850,477	8,006 Added 1.57%	519,372 $48.1 Million
Q1 2018 Apr 30, 2018	BUY	$92.01 - $123.21 $226,068 - $302,726	2,457 Added 0.48%	511,366 $48.4 Million
Q4 2017 Feb 02, 2018	BUY	$89.56 - $98.21 $602,111 - $660,265	6,723 Added 1.34%	508,909 $49.2 Million
Q3 2017 Oct 24, 2017	BUY	$69.85 - $89.22 $35.1 Million - $44.8 Million	502,186	502,186 $44.6 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Account

Huntington National Bank Abb Vie Inc. Transaction History